Complete response to neoadjuvant chemoradiotherapy in rectal cancer is associated with RAS/AKT mutations and high tumour mutational burden

S:CORT Consortium

Research output: Contribution to journalArticlepeer-review

124 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Complete response to neoadjuvant chemoradiotherapy in rectal cancer is associated with RAS/AKT mutations and high tumour mutational burden'. Together they form a unique fingerprint.

Medicine & Life Sciences